Skip to main content
Equibles

STEMPOINT CAPITAL LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1952142 NEW YORK, NY
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,622,125
-$1,777,394 QoQ
Shares Held
143,167
-41.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#87
of 354 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. ACAD ranks #43 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TNGX
Tango Therapeutics, Inc.
 1,223,019 $38,231,573
2 ABVX
Abivax S.A.
 283,657 $37,800,131
3 RVMD
Revolution Medicines, Inc.
 159,943 $29,954,125
4 ERAS
Erasca, Inc.
 1,565,913 $28,687,526
5 TYRA
Tyra Biosciences, Inc.
 632,754 $20,210,162
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 200,851 $19,578,955
7 ELVN
Enliven Therapeutics, Inc.
 346,914 $17,605,885
8 MLYS
Mineralys Therapeutics, Inc.
 602,686 $16,260,468

All Filings in ACAD

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,622,125 143,167
2026-03-31 $5,399,519 242,566